Lipocine announces US FDA labelling changes for testosterone products
Lipocine Inc., a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, announced that the US Food and Drug Administration (FDA) has recently informed sponsors of approved …